TI - <prot>  MyoD </prot>  prevents <p1  pair=3 >  <prot>  cyclinA </prot>  </p1>  / <p2  pair=3 >  <prot>  cdk2 </prot>  </p2>  containing <prot>  E2F </prot>  complexes formation in terminally differentiated myocytes .
PG - 1171 - 84 AB - Withdrawal from the cell cycle of differentiating myocytes is regulated by the <prot>  myogenic basic helix - loop - helix </prot>  ( <prot>  bHLH </prot>  ) protein <prot>  MyoD </prot>  and the pocket proteins <prot>  pRb </prot>  , <prot>  p107 </prot>  and <prot>  pRb2 </prot>  / <prot>  p130 </prot>  .
Downstream effectors of ' pocket ' proteins are the components of the <prot>  E2F </prot>  family of transcription factors , which regulate the G1 / S - phase transition .
We analysed by EMSA the composition of <prot>  E2F </prot>  complexes in cycling , quiescent undifferentiated and differentiated C2C12 skeletal muscle cells .
An <prot>  E2F </prot>  complex containing mainly <p1  pair=1 >  <p1  pair=2 >  <prot>  E2F4 </prot>  </p1>  </p1>  and <p2  pair=1 >  <prot>  pRb2 </prot>  </p2>  / <p2  pair=2 >  <prot>  p130 </prot>  </p2>  ( <prot>  E2F </prot>  - G0 / G1 complex ) appears when DNA synthesis arrests , replacing the <p1  pair=4 >  <prot>  cyclinA </prot>  </p1>  / <p2  pair=4 >  <prot>  cdk2 </prot>  </p2>  containing <prot>  E2F </prot>  complex of proliferating myoblasts ( <prot>  E2F </prot>  - G1 / S complex ) .
Serum stimulation reinduces DNA synthesis and the re - appearance of <prot>  E2F </prot>  - G1 / S complexes in quiescent myoblasts but not in differentiated C2C12 myotubes .
In differentiating C2C12 cells , <prot>  E2F </prot>  complexes switch and DNA synthesis in response to serum are prevented when <prot>  MyoD </prot>  DNA binding activity and the cdks inhibitor <prot>  MyoD </prot>  downstream effector <prot>  p21 </prot>  are induced .
Thus , during myogenic differentiation , formation of <p1  pair=5 >  <p1  pair=6 >  <prot>  E2F4 </prot>  </p1>  </p1>  and <p2  pair=5 >  <prot>  pRb2 </prot>  </p2>  / <p2  pair=6 >  <prot>  p130 </prot>  </p2>  containing complexes is an early event , but not enough on its own to prevent the reactivation of DNA synthesis .
Using a subclone of C3H10T1 / 2 mouse fibroblasts stably expressing <prot>  Estrogen Receptor </prot>  - <prot>  MyoD </prot>  ( <prot>  ER </prot>  - <prot>  MyoD </prot>  ) chimerae , we found that estrogen directed <prot>  MyoD </prot>  activation prevents the reassociation of <p1  pair=7 >  <prot>  cyclinA </prot>  </p1>  / <p2  pair=7 >  <prot>  cdk2 </prot>  </p2>  to the <prot>  E2F4 </prot>  containing complex following serum stimulation and this correlates with suppression of <prot>  E2F </prot>  activity and the inability of cells to re - enter the cell cycle .
Our data indicate that , in differentiating myocytes , one mechanism through which <prot>  MyoD </prot>  induces permanent cell cycle arrest involves <prot>  p21 </prot>  upregulation and suppression of the proliferation - associated cdks - containing <prot>  E2F </prot>  complexes formation .
AD - Fondazione A Cesalpino and I Clinica Medica , University of Rome La
